Immune cells‐derived exosomes: A promising strategy for COVID‐19 treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune cells‐derived exosomes: A promising strategy for COVID‐19 treatment

Published:2022-10-10 Issue:4 Volume:2 Page:
ISSN:2768-0622
Container-title:Clinical and Translational Discovery
language:en
Short-container-title:Clinical and Translational Dis

Author:

Zhang Zichen¹,Long Jiangang²,Meng Lingjie³⁴,Yang Zhiwei¹²,Zhang Shengli¹,Zhang Lei¹

Affiliation:

1. MOE Key Laboratory for Nonequilibrium Synthesis and Modulation of Condensed Matter, School of Physics Xi'an Jiaotong University Xi'an China

2. School of Life Science and Technology Xi'an Jiaotong University Xi'an China

3. School of Chemistry Xi'an Jiaotong University Xi'an China

4. Instrumental Analysis Center Xi'an Jiaotong University Xi'an China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctd2.138

Reference18 articles.

1. The trinity of COVID-19: immunity, inflammation and intervention

2. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies

3. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup

4. COVID‐19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes: Potential Next-Generation Nanocarriers for the Therapy of Inflammatory Diseases;Pharmaceutics;2023-09-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP